Bull&Bear | Bullish Surge for Neuronetics and Sage Therapeutics, While Quantum Stocks Face Steep Declines

In the realm of bullish stocks, Neuronetics (STIM) saw a significant rise of 36.84%, marking its second consecutive day of gains, with a two-day increase of 56.00%. The company announced its fourth-quarter revenue of $22.1 million and projected a fiscal year 2024 revenue of $74.5 million. Additionally, it anticipates a revenue growth rate of 12%-19% for 2025 and aims to achieve $22 million in synergies by the same year. The company expects to reach cash flow breakeven by the third quarter of 2025.

Sage Therapeutics (SAGE) surged by 35.14%, largely driven by potential acquisition interest from Biogen. Analysts suggest that this buyout could significantly strengthen Biogen’s neurological strategy.

Intra-Cellular (ITCI) experienced a 34.07% increase over two days, accumulating gains of 54.06% during this period. Reports suggest Johnson & Johnson plans to acquire Intra-Cellular for billions, marking one of the largest biotechnology deals in recent years.

Standard BioTools (LAB) climbed by 26.38% over three consecutive days, with a total gain of 17.71% during this period. The stock's upward momentum followed the company's release of preliminary fourth-quarter and fiscal year 2024 financial results.

Baird Medical (BDMD) rose by 25.40%, maintaining a six-day rally with a staggering six-day increase of 116.99%. The market seems to be reacting to Baird Medical Investment Holding Ltd.'s strong financial standing, prompting questions about what is fueling this robust market performance.

On the bearish side, SEALSQ (LAES) fell sharply by 41.54%. The stock's decline has been painful for individual investors, who saw a decrease of 26% over the past week, alongside losses sustained by institutional investors.

D-Wave Quantum (QBTS) dropped 33.71% over four days, resulting in a 62.54% decline within this timeframe. The decline comes amidst the company's signing of a stock sale agreement valued at up to $150 million, causing a downturn in quantum stocks.

Rigetti Computing (RGTI) saw a decrease of 32.25% over four consecutive days, with a total four-day decline of 68.99%. The pressure on quantum stocks persisted, especially after Nvidia CEO Jensen Huang suggested that practical quantum computing might not become a reality for at least another 15 years.

Quantum Computing (QUBT) also tumbled by 27.39% over four days, marking a significant four-day drop of 63.96%. The continuous decline in quantum stocks was exacerbated by Nvidia CEO Huang’s comments, alongside Meta's Mark Zuckerberg's belief that practical applications might still be a distance away.

Quantum-Si (QSI) decreased by 27.03%. The company recently shared a preprint showcasing the power of protein barcodes as a transformative tool for proteomics, indicating potential shifts in the market due to this innovative approach.